17 days + paromomycin IM: 15 mg (11 mg base)/kg daily for 17 days Second-line treatment for relapse and for specific vulnerable groups: severe disease, pregnant women, patients over 45 years: liposomal amphotericin B IV infusion: 3 to 5 mg/kg once daily for 6 to 10 days up to a total dose of 30 mg/kg Treatment in HIV co-infected patients: liposomal amphotericin B IV infusion: 3 to 5 mg/kg once daily for 6 to 10 days up to a total dose of 30 mg/kg + miltefosine PO for 28 days: Children 2 to 11 years: 2.5 mg/kg once daily Children ≥ 12 years and < 25 kg: 50 mg once daily Children ≥ 12 years and adults 25 to 50 kg: 50 mg 2 times daily Adults > 50 kg: 50 mg 3 times daily Visceral leishmaniasis in South Asia First-line treatment: liposomal amphotericin B IV infusion: 3 to 5 mg/kg once daily for 3 to 5 days up to a total dose of 15 mg/kg or liposomal amphotericin B IV infusion: 10 mg/kg single dose Second-line treatment for relapse: liposomal amphotericin B IV infusion: 3 to 5 mg/kg once daily for 5 to 8 days up to a total dose of 25 mg/kg For all patients with visceral leishmaniasis, hydration, nutritional support and treatment of intercurrent infections (malaria, dysentery, pneumonia, etc.) are essential. Tuberculosis and/or HIV infection may also be present and should be suspected if relapse occurs more than once or in the event of treatment failure. Page 19 5/ 409